SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFS14A - Definitive proxy statement for special meeting:
SEC Accession No. 0000950123-00-001370
Filing Date
2000-02-16
Accepted
2000-02-16 00:00:00
Documents
1
Period of Report
2000-03-17

Document Format Files

Seq Description Document Type Size
1 ATLANTIC PHARMACEUTICALS, INC. DEFS14A 20467
  Complete submission text file 0000950123-00-001370.txt   21945
Mailing Address 1017 MAIN CAMPUS DRIVE SUITE 3900 RALEIGH NC 27605
Business Address 1017 MAIN CAMPUS DRIVE SUITE 3900 RALEIGH NC 27606 9195137020
ATLANTIC PHARMACEUTICALS INC (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFS14A | Act: 34 | File No.: 033-98478 | Film No.: 547152
SIC: 2834 Pharmaceutical Preparations